List of Tables
Table 1. Drugs for Asthma and COPD Market Trends
Table 2. Drugs for Asthma and COPD Market Drivers & Opportunity
Table 3. Drugs for Asthma and COPD Market Challenges
Table 4. Drugs for Asthma and COPD Market Restraints
Table 5. Global Drugs for Asthma and COPD Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Drugs for Asthma and COPD Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Drugs for Asthma and COPD Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Drugs for Asthma and COPD Product Type
Table 9. Key Companies Time to Begin Mass Production of Drugs for Asthma and COPD
Table 10. Global Drugs for Asthma and COPD Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Asthma and COPD as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Drugs for Asthma and COPD Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Drugs for Asthma and COPD Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Drugs for Asthma and COPD Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Drugs for Asthma and COPD Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Drugs for Asthma and COPD Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Drugs for Asthma and COPD Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Drugs for Asthma and COPD Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Drugs for Asthma and COPD Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Drugs for Asthma and COPD Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Drugs for Asthma and COPD Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Drugs for Asthma and COPD Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Drugs for Asthma and COPD Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Drugs for Asthma and COPD Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Drugs for Asthma and COPD Sales Value by Region (2019-2024) & (%)
Table 27. Global Drugs for Asthma and COPD Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Drugs for Asthma and COPD Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Drugs for Asthma and COPD Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Drugs for Asthma and COPD Sales Value, (2025-2030) & (US$ Million)
Table 31. GSK Basic Information List
Table 32. GSK Description and Business Overview
Table 33. GSK Drugs for Asthma and COPD Products, Services and Solutions
Table 34. Revenue (US$ Million) in Drugs for Asthma and COPD Business of GSK (2019-2024)
Table 35. GSK Recent Developments
Table 36. AstraZeneca Basic Information List
Table 37. AstraZeneca Description and Business Overview
Table 38. AstraZeneca Drugs for Asthma and COPD Products, Services and Solutions
Table 39. Revenue (US$ Million) in Drugs for Asthma and COPD Business of AstraZeneca (2019-2024)
Table 40. AstraZeneca Recent Developments
Table 41. Boehringer Ingelheim Basic Information List
Table 42. Boehringer Ingelheim Description and Business Overview
Table 43. Boehringer Ingelheim Drugs for Asthma and COPD Products, Services and Solutions
Table 44. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Boehringer Ingelheim (2019-2024)
Table 45. Boehringer Ingelheim Recent Developments
Table 46. Vertex Basic Information List
Table 47. Vertex Description and Business Overview
Table 48. Vertex Drugs for Asthma and COPD Products, Services and Solutions
Table 49. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Vertex (2019-2024)
Table 50. Vertex Recent Developments
Table 51. Roche Basic Information List
Table 52. Roche Description and Business Overview
Table 53. Roche Drugs for Asthma and COPD Products, Services and Solutions
Table 54. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Roche (2019-2024)
Table 55. Roche Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Drugs for Asthma and COPD Products, Services and Solutions
Table 59. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. Teva Basic Information List
Table 62. Teva Description and Business Overview
Table 63. Teva Drugs for Asthma and COPD Products, Services and Solutions
Table 64. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Teva (2019-2024)
Table 65. Teva Recent Developments
Table 66. Chiesi Basic Information List
Table 67. Chiesi Description and Business Overview
Table 68. Chiesi Drugs for Asthma and COPD Products, Services and Solutions
Table 69. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Chiesi (2019-2024)
Table 70. Chiesi Recent Developments
Table 71. Mylan Basic Information List
Table 72. Mylan Description and Business Overview
Table 73. Mylan Drugs for Asthma and COPD Products, Services and Solutions
Table 74. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Mylan (2019-2024)
Table 75. Mylan Recent Developments
Table 76. Sumitomo Dainippon Basic Information List
Table 77. Sumitomo Dainippon Description and Business Overview
Table 78. Sumitomo Dainippon Drugs for Asthma and COPD Products, Services and Solutions
Table 79. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Sumitomo Dainippon (2019-2024)
Table 80. Sumitomo Dainippon Recent Developments
Table 81. Merck Basic Information List
Table 82. Merck Description and Business Overview
Table 83. Merck Drugs for Asthma and COPD Products, Services and Solutions
Table 84. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Merck (2019-2024)
Table 85. Merck Recent Developments
Table 86. Beximco Basic Information List
Table 87. Beximco Description and Business Overview
Table 88. Beximco Drugs for Asthma and COPD Products, Services and Solutions
Table 89. Revenue (US$ Million) in Drugs for Asthma and COPD Business of Beximco (2019-2024)
Table 90. Beximco Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Drugs for Asthma and COPD Downstream Customers
Table 94. Drugs for Asthma and COPD Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Drugs for Asthma and COPD Product Picture
Figure 2. Global Drugs for Asthma and COPD Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Drugs for Asthma and COPD Sales Value (2019-2030) & (US$ Million)
Figure 4. Drugs for Asthma and COPD Report Years Considered
Figure 5. Global Drugs for Asthma and COPD Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Drugs for Asthma and COPD Revenue in 2023
Figure 7. Drugs for Asthma and COPD Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Inhalable & Nasal Spray Picture
Figure 9. Oral Picture
Figure 10. Others Picture
Figure 11. Global Drugs for Asthma and COPD Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Drugs for Asthma and COPD Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Asthma
Figure 14. Product Picture of COPD
Figure 15. Global Drugs for Asthma and COPD Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Drugs for Asthma and COPD Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Drugs for Asthma and COPD Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Drugs for Asthma and COPD Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Drugs for Asthma and COPD Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Drugs for Asthma and COPD Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Drugs for Asthma and COPD Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Drugs for Asthma and COPD Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Drugs for Asthma and COPD Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Drugs for Asthma and COPD Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Drugs for Asthma and COPD Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Drugs for Asthma and COPD Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Drugs for Asthma and COPD Sales Value (%), (2019-2030)
Figure 28. United States Drugs for Asthma and COPD Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Drugs for Asthma and COPD Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Drugs for Asthma and COPD Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Drugs for Asthma and COPD Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Drugs for Asthma and COPD Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Drugs for Asthma and COPD Sales Value by Application (%), 2023 VS 2030
Figure 34. China Drugs for Asthma and COPD Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Drugs for Asthma and COPD Sales Value by Type (%), 2023 VS 2030
Figure 36. China Drugs for Asthma and COPD Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Drugs for Asthma and COPD Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Drugs for Asthma and COPD Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Drugs for Asthma and COPD Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Drugs for Asthma and COPD Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Drugs for Asthma and COPD Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Drugs for Asthma and COPD Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Drugs for Asthma and COPD Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Drugs for Asthma and COPD Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Drugs for Asthma and COPD Sales Value by Application (%), 2023 VS 2030
Figure 46. India Drugs for Asthma and COPD Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Drugs for Asthma and COPD Sales Value by Type (%), 2023 VS 2030
Figure 48. India Drugs for Asthma and COPD Sales Value by Application (%), 2023 VS 2030
Figure 49. Drugs for Asthma and COPD Industrial Chain
Figure 50. Drugs for Asthma and COPD Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
